Dr Mubasher Qamar is a Clinical and Research Fellow in Neurology at King’s College Hospital and a PhD Fellow and Trial Physician at King’s College London, based within the Institute of Psychiatry, Psychology & Neuroscience. He joined King’s in 2022, where he works within the Centre for Healthy Brain Ageing contributing to a broad portfolio of early-phase clinical trials and observational studies in neurodegenerative disorders.

His research focuses on Parkinson’s disease and dementia, with particular interests in clinical trial delivery, biomarker development, and service innovation. He has expertise in the design and conduct of phase I–II clinical trials (CTIMPs), and leads and supports multiple studies as Chief Investigator, Principal Investigator, and Sub-Investigator. His work also includes the development of novel service improvement tools, such as pre-clinic questionnaires, and the evaluation of non-pharmacological interventions including structured exercise programmes.

Dr Qamar is actively involved in national and international research collaborations and contributes to trial methodology, patient recruitment strategies, and multidisciplinary clinical research delivery. He is also engaged in education and training through his roles with the Movement Disorder Society and research ethics committees.

He holds multiple postgraduate qualifications, including an MSc in Clinical Neuroscience, an MSc in Medical Education, and is currently completing an MSc in Clinical Research Delivery alongside his PhD at King’s College London. He obtained his primary medical qualification in the UK and has undertaken worked as a physician in neurology and clinical research.

Research Interests

• Parkinson’s disease and related movement disorders
• Dementia, including Alzheimer’s disease and Lewy body dementia
• Early-phase clinical trials (Phase I–II) in neurodegenerative diseases
• Biomarker development (plasma, CSF, and skin biopsy-based diagnostics)
• Clinical trial design, delivery, and recruitment strategies
• Non-pharmacological interventions (e.g., exercise and Tai Chi in Parkinson’s disease)
• Service innovation and quality improvement in neurology clinics
• Digital health tools and remote monitoring in neurodegenerative diseasePatient-reported outcomes and pre-clinic assessment tools
• Research registries and consent-to-contact platforms for participant recruitment
• Multidisciplinary care models in Parkinson’s disease and dementia

Research Groups 

• King's Parkinson's Foundation CoE Research Team
• Centre of Healthy Brain Ageing Research Team
• Co-Chair of Education Committee at the International Movement Disorder Society
• Member of the Risk Assessment Committee (RAC) at IOPPN
• Member of the South London Research Ethics Committee (REC)
• Member of the UK Clinical Research Network
• Member of the European Neurology of Academy
• Member of the International Movement Disorder Society
• Member of the British Neurology Association

Expertise and Public Engagement 

• Lead of the PPI at KCH PD team - CRISP
• Annual lecture to PD community team in Barnet
• Work closely with AD and PD UK society for annual ethnic minioty gorup engagement
• Spoken on BBC Radio for Parkinson's Day
• Spoken to Islamic Radio UK for research engagement
• Invited lecturer for Pint of Science

Additional Information

Dr Mubasher Qamar is committed to advancing equitable access to clinical research and improving patient engagement across diverse populations. His work emphasises inclusive recruitment strategies and the development of scalable research infrastructure, including research registries and consent-to-contact platforms.

He has a strong interest in translating research into real-world clinical practice, particularly through service innovation and the integration of digital tools within routine care. This includes the development of patient-centred approaches to improve clinic efficiency, communication, and shared decision-making.

In addition to his research activities, Dr Qamar is actively involved in education, mentorship, and the training of early-career clinicians and researchers. He contributes to national and international initiatives aimed at improving standards in clinical research delivery and movement disorders care.